This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Does recent randomized prostate cancer trial provide insights on best treatment?

January 12th, 2017

For the first time, we now have a randomized trial comparing active monitoring, surgery, and radiation therapy for the management of localized prostate cancer. In a recent BJU International article, experts note that the investigators are to be congratulated on their highly anticipated landmark study, the Prostate testing for cancer and Treatment (ProtecT) trial; however, they point to several limitations in the recruitment of patients for the study and differences in the active monitoring protocol in the study compared with contemporary practice.

Considerable advances in treatment methods after the trial may also limit the results' relevance to current care.

"The utilization of observational data continues to be important in current times," the authors wrote.

More information:
Luke L. Wang et al, ‘ProtecTion’ from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?, BJU International (2017). DOI: 10.1111/bju.13734

Provided by Wiley

Citation: Does recent randomized prostate cancer trial provide insights on best treatment? (2017, January 12) retrieved 28 September 2025 from https://sciencex.com/wire-news/245681600/does-recent-randomized-prostate-cancer-trial-provide-insights-on.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.